These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6849783)

  • 41. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
    Sanders GL; Murray A; Rawlins MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
    Mabie WC; Gonzalez AR; Sibai BM; Amon E
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):328-33. PubMed ID: 3306494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elimination kinetics of labetalol in severe renal failure.
    Wood AJ; Ferry DG; Bailey RR
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):81S-86S. PubMed ID: 7093103
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response & Side Effects of Injectable Labetalol in Pregnancy Induced Severe Hypertension.
    Akter FA; Nahar K; Rahman MM; Ferdousi RA; Ahmed MU; Begum F; Biswas D; Alom M; Hossain MZ; Razi RZ
    Mymensingh Med J; 2017 Jul; 26(3):608-613. PubMed ID: 28919617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.
    Walker JJ; Greer I; Calder AA
    Postgrad Med J; 1983; 59 Suppl 3():168-70. PubMed ID: 6647203
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transfer of labetalol into amniotic fluid and breast milk in lactating women.
    Lunell NO; Kulas J; Rane A
    Eur J Clin Pharmacol; 1985; 28(5):597-9. PubMed ID: 4043203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial.
    Baggio MR; Martins WP; Calderon AC; Berezowski AT; Marcolin AC; Duarte G; Cavalli RC
    Ultrasound Med Biol; 2011 Jan; 37(1):53-8. PubMed ID: 21084154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Labetalol: the nineteen-eighties.
    Robertson JI
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):137S-141S. PubMed ID: 7093098
    [No Abstract]   [Full Text] [Related]  

  • 49. Labetalol: potent antihypertensive agent that blocks both alpha- and beta-adrenergic receptors.
    Milne BJ; Logan AG
    Can Med Assoc J; 1980 Nov; 123(10):1013-6. PubMed ID: 6256045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial].
    Plouin PF; Bréart G; Maillard F; Papiernik E; Relier JP
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):952-5. PubMed ID: 3116996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):239S-244S. PubMed ID: 526408
    [No Abstract]   [Full Text] [Related]  

  • 52. Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
    Hussein M; Mooij JM; Roujouleh H
    Kidney Blood Press Res; 2001; 24(2):124-8. PubMed ID: 11435745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol.
    Lardoux H; Gerard J; Blazquez G; Chouty F; Flouvat B
    Eur Heart J; 1983 Nov; 4 Suppl G():35-40. PubMed ID: 6662119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Labetalol: bioavailability, drug plasma levels, plasma renin and catecholamines in acute and chronic treatment of resistant hypertension.
    Louis WJ; Christophidis N; Brignell M; Vijayasekaran V; McNeil J; Vajda FJ
    Aust N Z J Med; 1978 Dec; 8(6):602-9. PubMed ID: 285681
    [No Abstract]   [Full Text] [Related]  

  • 56. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physiologic Treatment of Severe Hypertension in Pregnancy and Postpartum.
    Davis AM; Blanchard CT; Subramaniam A; Sinkey RG; Tita AT; Battarbee AN
    Obstet Gynecol; 2024 Feb; 143(2):277-280. PubMed ID: 38033320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
    Cummings AM; Brown JJ; Fraser R; Lever AF; Morton JJ; Richards DA; Robertson JI
    Br J Clin Pharmacol; 1979 Oct; 8(4):359-64. PubMed ID: 508511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of fenoterol on blood pressure, heart rate, and cardiotocogram of hypertensive and normotensive women in advanced pregnancy (author's transl)].
    Oddoy A; Joschko K
    Zentralbl Gynakol; 1982; 104(7):415-21. PubMed ID: 7102159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Labetalol steady-state pharmacokinetics in hypertensive patients.
    McNeil JJ; Anderson AE; Louis WJ; Raymond K
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):75S-80S. PubMed ID: 7093102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.